
AI Biomedical R&D Company
Catalog medium is a universal type of cell culture medium,Usually providing basic nutrients for cell growth and reproduction, including amino acids, vitamins, inorganic salts, etc. With the rapid development of the modern pharmaceutical industry, the limitations of ordinary catalog media in adaptability and expression efficiency are difficult to meet the higher demands of bioprocessing. GBB's AlfaMedX platform has launched intelligent catalog media.
AlfaMedXThe platform applies artificial intelligence (AI) technology to the development of cell culture medium formulations, establishes a medium formulation algorithm platform, and develops catalog media suitable for cell growth and protein expression.
▲AlfaMedX (NF3370+DF2025) Catalog Media
Product Attributes
1. The chemical composition of the medium is determined and contains no animal-derived components.
2. Contains amino acids, vitamins, glucose, lipids, inorganic salts, and trace elements, but does not contain growth factors, cholesterol, polypeptides, hydrolysates, or phenol red.
3. Dry powder medium contains P188 and HT, but no L-glutamine.。
· Protein expression is equivalent to or better than commercial culture medium
· Expression level surpasses 75% of commercial culture media both in China and internationally
· With good universality
· CHO-K1 cell lines suitable for expressing different products
· Combined with the medium optimization platform AlfaOPA, the expression level can reach the ceiling.
· Provide customized culture media to maximize the efficacy of the media.
· Shorten the product development cycle
· Significantly reduce users' initial investment
AlfaMedX (NF3370+DF2025) catalog media has been compared with the expression levels of various commercial media both in China and internationally, demonstrating excellent performance in case studies.





▲Comparison of 8 Experimental Cases and Data Statistics
AlfaMedX (NF3370+DF2025) protein expression is equivalent to or better than commercially available media in China and internationally.The optimal ratio accounts for 75%, and the top two ratios reach 100%.。
AlfaMedX (NF3370+DF2025) has good universality and is suitable for expressing different products in CHO-K1 cell lines.
Currently, the AlfaMedX platform has limited free evaluation slots available for a trial activity. Interested colleagues can scan the QR code below to contact us for scheduling an experience.

END
Phone: 400 079 8808
18926497707 (Same number on WeChat)
Email: BD@greatbay-bio.com
